Literature DB >> 15969234

[Evaluation of the antibiotics consumption in a Tunisian university hospital].

H Kallel1, C Hedi, I Maaloul, M Bahloul, H Ksibi, B Khémakhem, C Ben Hamida, N Rekik, A Jarraya, A Hammami, M Ben Jemâa, M Bouaziz.   

Abstract

PURPOSE: To estimate the consumption of antibiotics in our hospital and to determine the points at which will be targeted the recommendations of good practice of antibiotherapy. PATIENTS AND METHODS: Our study is a one day prevalence study where antibiotic's prescriptions are analyzed by a group of 6 doctors referents in antibiotherapy.
RESULTS: During the study day, 443 patients were studied. Means age was 44.2 +/- 23.3 years (range: 1 and 102 years). 101 infections were diagnosed in 48 patients (10.8%). 192 patients (43.3%) received antibiotics. Antibiotherapy was curative in 44% of cases. The most prescribed antibiotics were gentamicin (85.2 DDD/1000 patients), metronidazole (79 DDD/1000 patients), and cefotaxime (73.9 DDD/1000 patients). According to the evaluation group, 30.7% of the antibiotic's prescription was considered unjustified. The antibioprophylaxis represents the category most often unjustified (49%). The molecules in which prescription was frequently considered unjustified are the ciprofloxacin (67%), the amoxicilline-clavulanate (40%) and the cefotaxime (40%).
CONCLUSION: Our results suggest that an action of good practice should be targeted at the antibioprophylaxis and should concern especially molecules in which prescription was frequently unjustified.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15969234

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  1 in total

1.  Correlation between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a medical-surgical intensive care unit.

Authors:  Hatem Kallel; Fouzia Mahjoubi; Hassen Dammak; Mabrouk Bahloul; Chokri Ben Hamida; Hedi Chelly; Noureddine Rekik; Adnéne Hammami; Mounir Bouaziz
Journal:  Indian J Crit Care Med       Date:  2008-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.